Lenvatinib Mesylate and Polatuzumab Vedotin-piiq
Determining the interaction of Lenvatinib Mesylate and Polatuzumab Vedotin-piiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab vedotin, Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Polio vaccine, inactivated
- Lenvatinib Mesylate-Poliovirus Vaccine (Inactivated)
- Lenvatinib Mesylate-Poliovirus vaccine, inactivated Injection
- Lenvatinib Mesylate-Polivy
- Lenvatinib Mesylate-Polmon
- Lenvatinib Mesylate-Polocaine
- Polatuzumab Vedotin-piiq-Lenvima
- Polatuzumab Vedotin-piiq-Lenvima (14 MG Daily Dose)
- Polatuzumab Vedotin-piiq-Lenvima (18 MG Daily Dose)
- Polatuzumab Vedotin-piiq-Lenvima (20 MG Daily Dose)
- Polatuzumab Vedotin-piiq-Lenvima (24 MG Daily Dose)
- Polatuzumab Vedotin-piiq-Lenvima (8 MG Daily Dose)